Cover Image

acNASH index to diagnose nonalcoholic steatohepatitis: A prospective derivation and global validation study

There is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohe-patitis (NASH) in non-specialized settings. We aimed to develop and validate a non-invasive test for diagnos -ing NASH in individuals with biopsy-proven nonalcoholic fatty liver disease (NAFLD). Methods: We...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wu, Xi-Xi, Zheng, Kenneth, Boursier, Jerome, Chan, Wah-Kheong, Yilmaz, Yusuf, Romero-Gomez, Manuel, El Kassas, Mohamed, Targher, Giovanni, Byrne, Christopher D., Huang, Zhi-Ming, Zheng, Ming-Hua
Format:	Article
Published:	Elsevier 2021
Subjects:	R Medicine RC Internal medicine
Online Access:	http://eprints.um.edu.my/34478/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
by: Chan, Wah Kheong, et al.
Published: (2017)

Molecular mechanism of tualang honey on 12% cholesterol diet induced nonalcoholic steatohepatitis (NASH) animal model
by: Abdul Rahim, Roslina, et al.
Published: (2018)

Non-alcoholic steatohepatitis (NASH) animal model
by: Abdul Rahim, Roslina, et al.
Published: (2021)

Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: Data From the global non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) registry
by: Younossi, Zobair M., et al.
Published: (2022)

Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease
by: Gao, Feng, et al.
Published: (2020)

Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems
by: Leung, Howard Ho-Wai, et al.
Published: (2022)

Molecular mechanisms underlying the effect of pioglitazone therapy in Non-Alcoholic Steatohepatitis (NASH)
by: Abdul Rahim, Roslina, et al.
Published: (2009)

Tualang honey effects on high cholesterol diet induced nonalcoholic steatohepatitis in an animal model
by: Hamad Mohamed, Zenab B., et al.
Published: (2018)

A global survey of physicians knowledge about nonalcoholic fatty liver disease
by: Younossi, Zobair M., et al.
Published: (2022)

Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
by: Alqahtani, Saleh A., et al.
Published: (2023)

Comparison between obese and non-obese nonalcoholic fatty liver disease
by: Chan, Wah Kheong
Published: (2023)

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
by: Younossi, Zobair M., et al.
Published: (2024)

Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
by: Kamarajah, Sivesh Kathir, et al.
Published: (2019)

Hepatocellular carcinoma in a non-B non-C non-alcoholic steatohepatitis (NBNC-NASH HCC)
by: M. F., Fairudz, et al.
Published: (2010)

Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
by: Zhou, Yu‐Jie, et al.
Published: (2021)

Prevalence of Ultrasound Diagnosed Nonalcoholic Fatty Liver Disease Among Rural Indigenous Community of Sarawak And Its Association With Biochemical and Anthropometric Measures
by: Cheah, W.L, et al.
Published: (2013)

Non-alcoholic steatohepatitis animal model induction
by: Abdul Rahim, Roslina, et al.
Published: (2019)

Tualang honey improves non alcoholic steatohepatitis animal model
by: Abdul Ghani, Azril Shahreez, et al.
Published: (2016)

Tualang honey improves non alcoholic steatohepatitis animal model
by: Abdul Ghani, Azril Shahreez, et al.
Published: (2016)

Nonalcoholic Fatty Liver Disease A Unique Entity or Part of the Metabolic Syndrome or Both
by: Yip, Terry Cheuk-Fung, et al.
Published: (2023)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
by: Pitisuttithum, Panyavee, et al.
Published: (2020)

Steatohepatitis and fibrosis in chronic Hepatitis C patients: is there any association?
by: Hasmoni, Mohamed Hadzri, et al.
Published: (2011)

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease
by: Sun, Chao, et al.
Published: (2024)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
by: Pitisuttithum, Panyavee, et al.
Published: (2020)

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
by: Chan, Wah Kheong, et al.
Published: (2018)

Effect of tualang honey on non-alcoholic steatohepatitis rat model
by: Abdul Ghani, Azril Shahreez, et al.
Published: (2017)

Nonalcoholic fatty liver disease: A global perspective
by: Wong, Wei Kei, et al.
Published: (2021)

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
by: Ting, Yi-Wen, et al.
Published: (2021)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis
by: Alam, Shahinul, et al.
Published: (2021)

The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur
by: Moy, Foong Ming, et al.
Published: (2010)

Tualang honey supplementation attenuates the lipid profile In high cholesterol diet induced non-alcoholic steatohepatitis animal model
by: Alias, Mohd Afzal, et al.
Published: (2021)

Diagnosing and treating cortisol insufficiency in ICU
by: Mat Nor, Mohd Basri
Published: (2013)

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
by: Chan, Wah Kheong, et al.
Published: (2018)

Microarray data analysis to identify differentially expressed genes and biological pathways associated with Tualang Honey supplementation in NASH animal model
by: Alias, Mohd Afzal, et al.
Published: (2021)

Nonalcoholic fatty liver disease and risk of early-onset vasomotor symptoms in lean and overweight premenopausal women
by: Cho, Yoosun, et al.
Published: (2022)

Why are nasopharyngeal carcinoma patients diagnosed at late stage?
by: Prasad, Umapati, et al.
Published: (1999)

Dilemma of diagnosing OCD: a case report
by: Ridzwan, Hijaz, et al.
Published: (2017)

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
by: Eslam, Mohammed, et al.
Published: (2020)

A common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: A meta-analysis
by: Zain, Shamsul Mohd, et al.
Published: (2014)

Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
by: Kakudi, Habeebah Adamu, et al.
Published: (2019)